Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2023 | 09-2022 | 09-2021 | 09-2020 | 09-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 6 | 6 | 81 | 101 |
| Inventories | N/A | N/A | N/A | 2 | 40 |
| TOTAL | $0 | $10 | $6 | $89 | $141 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | 1 | 1 |
| TOTAL | $0 | $0 | $0 | $1 | $1 |
| Total Assets | $0 | $10 | $6 | $90 | $142 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 60 | 20 | 20 | 155 | 114 |
| Accounts payable and accrued liabilities | 843 | 820 | 402 | 367 | 486 |
| Accrued Expenses | 225 | 226 | 224 | 227 | 228 |
| TOTAL | $1,434 | $1,205 | $732 | $749 | $828 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,434 | $1,205 | $732 | $749 | $828 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,026,417 | 770,361 | 600,375 | 445,493 | 210,301 |
| Common Shares | 996 | 722 | 562 | 436 | 171 |
| Retained earnings | -20,454 | -18,505 | -17,017 | -7,215 | -6,674 |
| Other shareholders' equity | 0 | 5 | 500 | 0 | 0 |
| TOTAL | $-1,434 | $-1,195 | $-726 | $-659 | $-685 |
| Total Liabilities And Equity | $0 | $10 | $6 | $90 | $142 |